Improving mood in older African American breast cancer survivors
Community Engagement in the Development of an Abbreviated Mindfulness-Based Cognitive Therapy Intervention for Depression in Older African American/Black Breast Cancer Survivors (Community Minds)
This study is testing a mindfulness program to see if it can help older African American women who have survived breast cancer and are dealing with depression feel better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 31 (estimated) |
| Ages | 65 Years and up |
| Sex | Female |
| Sponsor | Case Comprehensive Cancer Center Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Cleveland, Ohio) |
| Trial ID | NCT06336538 on ClinicalTrials.gov |
What this trial studies
This intervention aims to develop and test a mindfulness-based cognitive therapy (MBCT) program specifically for older African American/Black breast cancer survivors who experience high rates of depression. The study focuses on addressing the unique health disparities faced by this population, particularly the under-treatment of depression and its impact on health outcomes. Participants will be women aged 65 and older, who are at least three months post-active cancer treatment and exhibit mild to moderate depressive symptoms. The intervention seeks to provide a culturally relevant, non-pharmacological approach to improve mood and reduce depressive symptoms.
Who should consider this trial
Good fit: Ideal candidates for this study are African American/Black women aged 65 and older who have been diagnosed with Stage I, II, or III breast cancer and are experiencing mild to moderate depressive symptoms.
Not a fit: Patients with moderately severe or severe depression, or those with comorbid psychiatric illnesses that interfere with participation, may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the mental health and overall well-being of older African American breast cancer survivors.
How similar studies have performed: Other studies have shown success in treating depression in cancer patients using similar non-pharmacological approaches, indicating potential for this intervention.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥65 years old * fluency in English * female * African American/Black * diagnosis of Stage I, II or III breast cancer * at least 3 months past active treatment for cancer (chemotherapy, surgery and/or radiation therapy) with no additional treatment scheduled except endocrine therapy * mild to moderate symptoms of depression (Patient Health Questionnaire-9(26) scores 4-14) * willing to be audio and video-recorded * willing to provide written informed consent. Exclusion Criteria: * moderately severe or severe depression (PHQ-9 scores ≥15) * comorbid psychiatric illness or other psychological disorders that would interfere with the ability to participate in or receive benefit from MBCT-Brief, including generalized social anxiety disorder, panic disorder, post-traumatic stress disorder, obsessive-compulsive disorder, drug abuse or dependence, bipolar disorder, borderline personality disorder, and active suicidal ideation. * changes in antidepressant medication within 6 weeks of intake * prior history of engaging in formal MBIs including Mindfulness-Based Stress Reduction, MBCT, Acceptance and Commitment Therapy, Dialectical Behavior Therapy * current daily meditation practice
Where this trial is running
Cleveland, Ohio
- Cleveland Clinic Department of Wellness and Preventive Medicine — Cleveland, Ohio, United States (Recruiting)
Study contacts
- Principal investigator: Jacob Hill, ND — Cleveland Clinic Department of Wellness and Preventive Medicine, Cleveland Clinic, Case Comprehensive Cancer Center
- Study coordinator: Jacob Hill, ND
- Email: hillj35@ccf.org
- Phone: 216-695-4897
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.